Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Active, not recruiting · NCT06654466 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, hereditary disease, hereditary neoplastic syndrome, neoplasm | Active, not recruiting | Not applicable | 2026-07-16 | NCT06654466 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| National Human Genome Research Institute (NHGRI) | 54 |
| Nest Genomics | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |